MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2018 International Congress

    The role of deep brain stimulation targeting GPi in patients with multiple system atrophy

    P. Hedera, D. Claassen, D. Isaacs (Nashville, TN, USA)

    Objective: To report clinical outcomes of two patients diagnosed with MSA-P who underwent bilateral deep brain stimulation (DBS). Background: The role of DBS in patients…
  • 2018 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Pagonabarraga-Mora, J. Marin-Lahoz, J. Pérez-Perez, A. Campolongo, C. izquierdo, H. Bejr-Kasen, I. Aracil, S. Martínez -Horta, A. Horta, M. Botí, E. Marin, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and after STN-DBS and compare their results with other recognized cognitive scales. Background: Deep brain stimulation of…
  • 2018 International Congress

    Evaluation of the Effect of STN-DBS on the Gastrointestinal Symptoms in Patients with Parkinson’s Disease via GIQLI

    A. Yilmaz, E. Okuyucu, M. Ugur (Hatay, Turkey)

    Objective: Our aim is to evaluate the effects of Subthalamic Nucleus (STN)-DBS on the quality of life in PD patients by using the Gastrointestinal Quality…
  • 2018 International Congress

    Long Term Response to L-dopa in Parkinson Disease

    H. Gupta, N. Wachter, K. Lyons, R. Pahwa (Kansas, KS, USA)

    Objective: To assess the long-term effectiveness of levodopa in Parkinson’s disease (PD) patients. Background: To date, levodopa continues to be the most efficacious drug in…
  • 2018 International Congress

    Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation (CLOVER-DBS)

    F. Sasaki, G. Oyama, S. Sekimoto, R. Nakamura, T. Jo, H. Iwamuro, A. Umemura, Y. Shimo, N. Hattori (Tokyo, Japan)

    Objective: To assess the feasibility and efficacy of a novel closed-loop programming algorithm (CLPA) for deep brain stimulation (DBS) based on objective feedback using a…
  • 2018 International Congress

    Deep brain stimulation outcomes for primary and secondary dystonia

    M. Carmona-Abellán, O. Parras, R. Valentí, J. Guridi, M. Alegre, R. Luquin-Piudo (Pamplona, Spain)

    Objective: To describe clinical outcomes of pallidal stimulation in different types of dystonia, both primary and secondary and long-term results. Background: Many studies have previously…
  • 2018 International Congress

    Optimizing the Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) outcome in Parkinson’s disease patient with interleaving stimulation

    C. Lau, C. Zhu, D. Chan, K. Ma, A. Chan, J. Yeung, V. Mok, W. Poon (Hong Kong)

    Objective: To explore interleaving versus conventional stimulation in subthlalmic nucleus (STN) deep brain stimulation (DBS) in optimizing the effect. Background: STN DBS is effective for…
  • 2018 International Congress

    Programming for Freezing of gait after Bilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease

    H. Zheng, F. Sun, L. Zhang (Nanjing, China)

    Objective: Freezing of gait (FOG) is a common gait disorder in Parkinson's disease (PD). In this study, we will adjust programming for patients with FOG…
  • 2018 International Congress

    Patient’s Choice of Device-Based Treatments in Parkinson’s Disease

    M. Kuzu Kumcu, S. Tezcan Aydemir, Ç. Ulukan, B. Bakırarar, C. Akbostancı (Ankara, Turkey)

    Objective: Deep brain stimulation of subtalamic nucleus (STN-DBS), subcutaneous apomorphine infusion (APO) and levodopa-carbidopa intestinal gel infusion (DUO) is routinely used in patients with advanced…
  • 2018 International Congress

    Impact of electrode impedance changes in clinical outcomes of patients with Parkinson’s disease and subthalamic nucleus deep brain stimulation

    ME. Contreras Pinto, J. Martins, C. Cerquera, S. Dias, D. Giraldo Salazar, JS. Saavedra Moreno, F. Vallderiola Serra (La Serena, Chile)

    Objective: To assess the longitudinal changes in impedance values of CV neurostimulation devices and its possible impact in the clinical outcome of PD patients with…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 152
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley